Making the most out of six systematic sextant biopsies

Urology

Volumn 45, Issue 1, 1995, Pages 2-12

  Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SIZE; CANCER STAGING; CLINICAL TRIAL; ECHOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW;

AGED; BIOPSY; HUMAN; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0028788603     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(95)96168-2     Document Type: Article

References (24)

1. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
2. Urological tumours: prostate
3. The TNM classification of prostate cancer
4. The New American Joint Committee on Cancer and International Union Against Cancer TNM Classification of Prostate Cancer
5. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men
6. Localized prostate cancer
7. Observations on the doubling time of prostate cancer: the use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume
8. Family history and prostate cancer risk in black, white and Asian men in the U.S. and Canada
9. Patterns of progression in prostate cancer
10. Histologic differentiation, cancer volume and pelvic lymph node metastasis in adenocarcinoma of the prostate
11. Spermatic cord metastasis from transitional cell carcinoma of the bladder.
12. Latent carcinoma of the prostate
13. Microcarcinoma of the prostate: its association with duct-acinar dysplasia
14. Identification of insignificant prostate cancers: analysis of preoperative parameters
15. Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen
16. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
17. Stage A versus Stage B adenocarcinoma of the prostate: morphologic comparison and biological significance
18. Zonal distribution of prostatic adenocarcinoma
19. The role of perineural space invasion in the local spread of prostatic adenocarcinoma
20. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma
21. Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen
22. Prostatic-specific antigen as a serum marker for adenocarcinoma of the prostate
23. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate: II. Radical prostatectomy treated patients